Lineage Cell Therapeutics (LCTX) Price to Sales (2011 - 2026)
Lineage Cell Therapeutics' Price to Sales was 25.32 in Q2 2026, up 33.0% from 19.04 a year earlier but down 5.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Price to Sales at Lineage Cell Therapeutics came in at 27.89, up 140.4% from FY2024.
- In earlier years, Price to Sales was 11.60 in FY2024 (-45.6%), 21.32 in FY2023 (+57.5%), 13.54 in FY2022 (-85.8%) and 95.65 in FY2021 (-33.8%).
- Quarterly Price to Sales has moved between 10.75 (Q1 2025) and 120.33 (Q3 2021) over five years.
- Compared with a year earlier, Price to Sales has increased for four straight quarters, with growth averaging 29.4% over the last eight quarters.
- The best year-over-year quarter for Price to Sales over five years was Q1 2026 (growth of 147.9%); the worst was Q2 2022 (a decline of 92.2%).
- Per Business Quant data, LCTX's Price to Sales in the three quarters before Q2 2026 was 26.65 (Q1 2026), 27.89 (Q4 2025) and 35.99 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.32 |
| Mar 31, 2026 | 26.65 |
| Dec 31, 2025 | 27.89 |
| Sep 30, 2025 | 35.99 |
| Jun 30, 2025 | 19.04 |
| Mar 31, 2025 | 10.75 |
| Dec 31, 2024 | 11.60 |
| Sep 30, 2024 | 19.71 |
| Jun 30, 2024 | 30.52 |
| Mar 31, 2024 | 34.91 |
| Dec 31, 2023 | 21.32 |
| Sep 30, 2023 | 23.54 |
| Jun 30, 2023 | 23.37 |
| Mar 31, 2023 | 21.54 |
| Dec 31, 2022 | 13.54 |
| Sep 30, 2022 | 13.76 |
| Jun 30, 2022 | 20.28 |
| Mar 31, 2022 | 28.45 |
| Dec 31, 2021 | 95.65 |
| Sep 30, 2021 | 120.33 |
API Access
Lineage Cell Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();